Silvia Pietrobono

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Journal of personalized medicine

Cancers

Cells

JCO precision oncology

Università degli Studi di Firenze

Università degli Studi di Siena (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Firenze Feb 06 2015

Italy

Post-doc fellowship :: Biomedical, Experimental and Clinical Sciences "Mario Serio"

Education History

Università degli Studi di Siena Feb 01 2012 - May 11 2015

Italy

PHD

Università degli Studi di Roma Tor Vergata Dipartimento di Biologia Feb 01 2008 - May 26 2011

Italy

MSC

Universita degli Studi di Roma Tor Vergata Sep 01 2002 - Feb 20 2007

Italy

BSC :: Department of Science and Chemical Technologies

Publications

Camilla Zecchetto, Alberto Quinzii, Simona Casalino, Marina Gaule, Camilla Pesoni, Valeria Merz, Silvia Pietrobono, Domenico Mangiameli, Martina Pasquato, Stefano Milleri, Simone Giacopuzzi, Maria Bencivenga, Anna Tomezzoli, Giovanni de Manzoni, Davide Melisi
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab. Journal of personalized medicine 13 (3) (2023)
Camilla Zecchetto, Alberto Quinzii, Simona Casalino, Marina Gaule, Camilla Pesoni, Valeria Merz, Silvia Pietrobono, Domenico Mangiameli, Martina Pasquato, Stefano Milleri, Simone Giacopuzzi, Maria Bencivenga, Anna Tomezzoli, Giovanni de Manzoni, Davide Melisi
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab. Journal of personalized medicine 13 (3) (2023)
Camilla Zecchetto, Alberto Quinzii, Simona Casalino, Marina Gaule, Camilla Pesoni, Valeria Merz, Silvia Pietrobono, Domenico Mangiameli, Martina Pasquato, Stefano Milleri, Simone Giacopuzzi, Maria Bencivenga, Anna Tomezzoli, Giovanni de Manzoni, Davide Melisi
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab. Journal of personalized medicine 13 (3) (2023)
Silvia Pietrobono, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli, Veronica De Vita, Federica Fazzini, Giulia Lunardi, Simona Casalino, Enza Scarlato, Valeria Merz, Camilla Zecchetto, Alberto Quinzii, Giusy Di Conza, Michael Lahn, Davide Melisi
Autotaxin secretion is a stromal mechanism of adaptive resistance to TGFβ inhibition in pancreatic ductal adenocarcinoma. Cancer research (2023)
Marina Gaule, Camilla Pesoni, Alberto Quinzii, Camilla Zecchetto, Simona Casalino, Valeria Merz, Serena Contarelli, Silvia Pietrobono, Elena Vissio, Luca Molinaro, Enrica Manzin, Roberta Volpatto, Giorgio Vellani, Davide Melisi
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. JCO precision oncology 6 (2022)
Silvia Pietrobono, Barbara Stecca
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention? Cancers 13 (9) (2021)
Silvia Pietrobono, Lorenzo Franci, Francesco Imperatore, Cristina Zanini, Barbara Stecca, Mario Chiariello
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis. Cancers 13 (19) (2021)
Silvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, Mariapaola Zitani, Laura Carrassa, Francesca Migliorini, Elena Petricci, Fabrizio Manetti, Nikolai Makukhin, Adam G Bond, Brooke D Paradise, Alessio Ciulli, Martin E Fernandez-Zapico, Francesco Bertoni, Barbara Stecca
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma. Oncogene 40 (22) (2021)
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, Domenico Mangiameli, Serena Contarelli, Silvia Pietrobono, Davide Melisi
The Multifaceted Role of TGF-β in Gastrointestinal Tumors. Cancers 13 (16) (2021)
Chiara De Vellis, Silvia Pietrobono, Barbara Stecca
The Role of Glycosylation in Melanoma Progression. Cells 10 (8) (2021)
Silvia Pietrobono, Giulia Anichini, Cesare Sala, Fabrizio Manetti, Luciana L Almada, Sara Pepe, Ryan M Carr, Brooke D Paradise, Jann N Sarkaria, Jaime I Davila, Lorenzo Tofani, Ilaria Battisti, Giorgio Arrigoni, Li Ying, Cheng Zhang, Hu Li, Alexander Meves, Martin E Fernandez-Zapico, Barbara Stecca
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nature communications 11 (1) (2020)
Silvia Pietrobono, Barbara Stecca
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors. Cells 7 (12) (2018)

Silvia Pietrobono.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia Pietrobono